Skip to content

The influence of ultrasound-guided intercostal plane block of the superior posterior saw muscle and paravertebral block on postoperative analgesia in patients undergoing thoracoscopic surgery

The influence of ultrasound-guided intercostal plane block of the superior posterior saw muscle and paravertebral block on postoperative analgesia in patients undergoing thoracoscopic surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112739
Enrollment
Unknown
Registered
2025-11-19
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracoscopic surgery

Interventions

Posterior serratus intercostal plane block group:Intercostal plane block of the posterior sawing muscle

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The patient's age ranges from 18 to 70 years old. 2. The anesthesia grade ASA is grade I to III. 3. Those who are scheduled to undergo thoracoscopic surgery; 4. Normal level of consciousness, no neurological or mental disorders. 5. The case data are complete and all have signed informed consent forms.

Exclusion criteria

Exclusion criteria: 1. There are contraindications to any of the drugs or techniques used in this study; 2. Has undergone intrathoracic surgery in the past; 3. Body mass Index (BMI) 25; 4. Pregnancy; 5. Pre-existing infection or severe inflammation at the puncture site. 6. Those who suffer from chronic pain (with unsatisfactory pain control for at least one month) and have been using sedative and analgesic drugs for a long time; Has a history of alcohol or drug dependence; 7. Those with abnormal coagulation systems; 8. Those with malignant tumors such as bone cancer and stomach cancer; 9. Those with diseases of vital organs such as the heart, lungs, liver, kidneys and brain; 10. Participate in other clinical trials.

Design outcomes

Primary

MeasureTime frame
The area under the curve of visual Analogue Scale score within 2 days after the operation;

Secondary

MeasureTime frame
Oral morphine equivalents of opioid consumption at 2 hours, 24 hours and 48 hours after the operation;QoR-15 scores at 2 hours, 24 hours and 48 hours after the operation;The proportion of patients with good recovery quality 24 hours after the operation (QoR-15 > 118);The range of dermatomial spread of nerve block is evaluated by acupuncture test 30 to 60 minutes after anesthesia recovery;Complication rate (including hematoma, infection, hypotension, bradycardia, urinary retention, drowsiness, pruritus, nausea and vomiting, etc.);Hospital stay;

Countries

China

Contacts

Public ContactWang Yun

Beijing Friendship Hospital, Capital Medical University

wangyun129@ccmu.edu.cn+86 135 2161 1825

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026